Advertisement
Home Blog Page 2067

May 2019 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for May 2019. This roundup includes the latest...

May 2019 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for May 2019. This roundup includes the...

May 2019 Briefing – HIV & AIDS

0
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for May 2019. This roundup includes...

May 2019 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for May 2019. This roundup includes the latest...

May 2019 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for May 2019. This roundup includes the...

May 2019 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for May 2019. This roundup includes...

May 2019 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for May 2019. This roundup includes the latest...

May 2019 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for May 2019. This roundup includes the latest...

May 2019 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for May 2019. This roundup includes the latest...
A public meeting on cannabidiol (CBD) products will be held Friday by the U.S. Food and Drug Administration

FDA to Hold First Public Meeting on CBD

0
Scheduled speakers will include doctors, consumers, and cannabis industry members